2 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Active not recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Completed 2 |
Follow Therapy: new trials by email Literature Review of Therapy trials Research Report on Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers (MT-2) Midomafetamine HCl, Therapy - Psychological Effects of Study Drug | Phase 1 | Withdrawn | Resilient Pharmaceuticals | 2024-12-01 | 2024-10-31 | |
| MDMA-Assisted Cognitive-Behavioral Conjoint Therapy (CBCT) in Dyads in Which 1 Member Has Chronic PTSD MDMA, CBCT, Therapy - Posttraumatic Stress Disorder | Phase 1 / Phase 2 | Completed | Resilient Pharmaceuticals | 12 | 2016-07-03 | 2025-06-04 |
| Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer Enzalutamide, Goserelin acetate, Leuprolide acetate - Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 1 | Active not recruiting | Thomas Jefferson University | 25 | 2014-04-02 | 2025-11-25 |
| PPARγ Agonist Treatment for Cocaine Dependence Pioglitazone, Placebo, Therapy - Cocaine Use Disorder, Alcohol Use Disorder | Phase 1 / Phase 2 | Completed | The University of Texas Health Science Center, Houston | 30 | 2012-08-01 | 2018-04-26 |
Alcoholism (1) · Prostatic Neoplasms (1) · Stress Disorders, Post-Traumatic (1)
Resilient Pharmaceuticals (2) · The University of Texas Health Science Center, Houston (1) · Thomas Jefferson University (1)
United States (3)
Joy M Schmitz, PhD (1) · Marcela Ot'alora (1) · Michael C Mithoefer, MD (1) · Robert Den, MD (1)
P50DA009262 (1)